Literature DB >> 17697529

Apocynin attenuates cerebral infarction after transient focal ischaemia in rats.

L L Tang1, K Ye, X F Yang, J S Zheng.   

Abstract

This study investigated whether inhibition of reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase attenuates cerebral infarction after transient focal ischaemia in rats. Focal ischaemia (1.5 h) was produced in male Sprague-Dawley rats (250 - 280 g) by middle cerebral artery occlusion. Some rats also received treatment with 50 mg/kg apocynin, a NADPH oxidase inhibitor, by intraperitoneal injection 30 min prior to reperfusion. Two hours after reperfusion, brains were harvested to measure NADPH oxidase activity and superoxide levels. After 24 h, the remaining brains were harvested to investigate infarct size. NADPH oxidase activity and superoxide level were all augmented 2 h after reperfusion compared with controls. Apocynin treatment significantly reduced NADPH oxidase activity and superoxide levels. Cerebral infarct size was significantly smaller in the apocynin-treated group compared with those undergoing ischaemia/reperfusion alone. These results indicate that inhibition of NADPH oxidase attenuates cerebral infarction after transient focal ischaemia in rats, suggesting that inhibition of NADPH oxidase may provide a therapeutic strategy for ischaemic stroke.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17697529     DOI: 10.1177/147323000703500411

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  45 in total

Review 1.  Oxidative stress and NAD+ in ischemic brain injury: current advances and future perspectives.

Authors:  W Ying; Z-G Xiong
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

Review 2.  Microglial activation in stroke: therapeutic targets.

Authors:  Midori A Yenari; Tiina M Kauppinen; Raymond A Swanson
Journal:  Neurotherapeutics       Date:  2010-10       Impact factor: 7.620

Review 3.  Targeting NOX enzymes in the central nervous system: therapeutic opportunities.

Authors:  Silvia Sorce; Karl-Heinz Krause; Vincent Jaquet
Journal:  Cell Mol Life Sci       Date:  2012-05-30       Impact factor: 9.261

Review 4.  NADPH oxidase in stroke and cerebrovascular disease.

Authors:  Xian Nan Tang; Belinda Cairns; Jong Youl Kim; Midori A Yenari
Journal:  Neurol Res       Date:  2012-05       Impact factor: 2.448

Review 5.  The role of the microglia in acute CNS injury.

Authors:  Masahito Kawabori; Midori A Yenari
Journal:  Metab Brain Dis       Date:  2014-03-29       Impact factor: 3.584

Review 6.  Synthetic and natural iron chelators: therapeutic potential and clinical use.

Authors:  Heather C Hatcher; Ravi N Singh; Frank M Torti; Suzy V Torti
Journal:  Future Med Chem       Date:  2009-12       Impact factor: 3.808

7.  Bone marrow chimeras in the study of experimental stroke.

Authors:  Xian Nan Tang; Zhen Zheng; Midori A Yenari
Journal:  Transl Stroke Res       Date:  2012-05-05       Impact factor: 6.829

8.  In Utero Exposure to Alcohol Impairs Reactivity of Cerebral Arterioles and Increases Susceptibility of the Brain to Damage Following Ischemia/Reperfusion in Adulthood.

Authors:  Sergio G Cananzi; William G Mayhan
Journal:  Alcohol Clin Exp Res       Date:  2019-03-07       Impact factor: 3.455

9.  Neuroendocrine profile in a rat model of psychosocial stress: relation to oxidative stress.

Authors:  Marilena Colaianna; Stefania Schiavone; Margherita Zotti; Paolo Tucci; Maria Grazia Morgese; Liselotte Bäckdahl; Rikard Holmdahl; Karl-Heinz Krause; Vincenzo Cuomo; Luigia Trabace
Journal:  Antioxid Redox Signal       Date:  2013-04-20       Impact factor: 8.401

10.  Reactive Oxygen Species-mediated Loss of Phenotype of Parvalbumin Interneurons Contributes to Long-term Cognitive Impairments After Repeated Neonatal Ketamine Exposures.

Authors:  Hui Zhang; Xiao-Ru Sun; Jing Wang; Zhen-Zhen Zhang; Hong-Ting Zhao; Hui-Hui Li; Mu-Huo Ji; Kuan-Yu Li; Jian-Jun Yang
Journal:  Neurotox Res       Date:  2016-07-21       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.